Longocaine solution for injection 2.5 mg/ml bottle 200 ml

Name: Longocaine solution for injection 2.5 mg/ml bottle 200 ml
SKU: an-49655
Price: 383.17 UAH
Availability: InStock

SKU: an-49655

All about product

Description

Specification

Reviews 0

Questions0

new

Hit

Longocaine solution for injection 2.5 mg/ml bottle 200 ml

In Stock

383.17 грн.

Active ingredient:Bupivacaine

Adults:Can

ATC code:N NERVOUS SYSTEM AGENTS; N01 ANESTHETICS; N01B LOCAL ANESTHETICS; N01B B Amides; N01B B01 Bupivacaine

Country of manufacture:Ukraine

Diabetics:Can

Delivery

USPS across the USA

Canada Post across Canada

Payment

Longocaine solution for injection 2.5 mg/ml bottle 200 ml

383.17 грн.

Description

Longocaine is prescribed for:

surgical anesthesia in adults and children over 12 years of age; relief of acute pain syndrome in adults, infants and children over 1 year of age.

Composition

Active ingredient: bupivacaine;

1 ml of solution contains bupivacaine hydrochloride anhydrous 2.5 mg;

Excipients: sodium chloride, water for injections.

Contraindication

Hypersensitivity to amide-type local anesthetics or to any of the other ingredients of the drug. Bupivacaine should not be used for intravenous regional anesthesia (Bieri block). Bupivacaine should not be used for epidural anesthesia in patients with severe hypotension, for example, in the case of cardiogenic or hypovolemic shock. Epidural anesthesia, regardless of the local anesthetic used, has its own contraindications, which include: diseases of the nervous system in the active stage, such as meningitis, poliomyelitis, intracranial hemorrhage, subacute combined degeneration of the spinal cord due to pernicious anemia and tumors of the brain and spinal cord; tuberculosis of the spine; purulent skin infection at or near the site of the lumbar puncture; blood clotting disorders or current treatment with anticoagulants.

Method of application

The drug should be administered by a physician experienced in regional anesthesia or under his supervision. Small doses should be used to achieve a sufficient degree of anesthesia.

Application features

Pregnant women

Should not be used in early pregnancy unless the benefits are considered to outweigh the risks.

Children

Use for anesthesia in children aged 1 year and older as directed.

Drivers

With caution.

Overdose

Accidental intravascular injections of local anesthetics can cause immediate (seconds to minutes) systemic toxic reactions. In case of overdose, systemic toxicity occurs later (15-60 minutes after injection) due to the slower increase in blood concentrations of the local anesthetic.

Side effects

Adverse reactions caused by the drug itself are difficult to distinguish from the physiological effects of nerve fiber blockade (e.g., decreased blood pressure, bradycardia), as well as phenomena caused directly (e.g., nerve injury) or indirectly (e.g., epidural abscess) by needle puncture.

Interaction

Caution should be exercised when using bupivacaine with drugs structurally similar to local anesthetics, such as class IC antiarrhythmics, as their toxic effects are additive.

Specific interaction studies between local anesthetics and class III antiarrhythmics (e.g. amiodarone) have not been performed, but caution is advised in this case.